These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3139755)

  • 1. Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumorous ascites.
    Cornelius JG; Normann SJ
    J Immunol; 1988 Sep; 141(6):2175-80. PubMed ID: 3139755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of an inhibitor of type II interferon induction from tumor ascitic fluids.
    Matsubara S; Suzuki M; Nakamura M; Edo K; Ishida N
    Cancer Res; 1980 Jul; 40(7):2534-8. PubMed ID: 6248207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and partial purification of a specific interleukin 2 inhibitor.
    Honda M; Chan C; Shevach EM
    J Immunol; 1985 Sep; 135(3):1834-9. PubMed ID: 3926886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lymphoid cell growth by a lipid-like component of macrophage hybridoma cells.
    Stallcup KC; Liu YN; Dorf ME; Mescher MF
    J Immunol; 1986 Apr; 136(8):2723-8. PubMed ID: 3958487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Purification of skin reactive factor (SRF) in mice].
    Fahlbusch B; Gutsche W; Zschiesche W
    Allerg Immunol (Leipz); 1976; 22(1):93-6. PubMed ID: 135506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal requirements for growth and differentiation of activated murine B lymphocytes.
    Müller W; Kühn R; Goldmann W; Tesch H; Smith FI; Radbruch A; Rajewsky K
    J Immunol; 1985 Aug; 135(2):1213-9. PubMed ID: 3874233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lung macrophages enhance and inhibit lymphocyte proliferation.
    Liu MC; Proud D; Schleimer RP; Plaut M
    J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). I. Isolation and characterization.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 Feb; 134(2):1019-25. PubMed ID: 3917468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
    Clark DA; Chaput A; Walker C; Rosenthal KL
    J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of anti-inflammatory factors produced by murine tumor cells in culture.
    Normann SJ; Cornelius J
    J Natl Cancer Inst; 1982 Dec; 69(6):1321-7. PubMed ID: 6815363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural identification of a major mitogenic lipid derived from Bacillus subtilis as a glycerophosphoglycolipid.
    Li Y; Gray GR
    Biochemistry; 1996 Dec; 35(50):16299-304. PubMed ID: 8973204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of IL-2-dependent proliferation by a prostaglandin-dependent suppressor factor.
    Ferreri NR; Herzog WR; Askenase PW
    J Immunol; 1993 Mar; 150(6):2102-11. PubMed ID: 8450204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and initial characterization of the lymphokine soluble immune response suppressor.
    Aune TM; Webb DR; Pierce CW
    J Immunol; 1983 Dec; 131(6):2848-52. PubMed ID: 6417233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor cell-inducing factor: a new lymphokine secreted by a natural suppressor cell line with natural cytotoxic activity. I. Purification to apparent homogeneity and initial characterization of suppressor cell-inducing factor.
    Almawi WY; Dolphin PJ; Thies RL; McMaster WR; Levy JG; Pope BL
    J Immunol; 1988 Oct; 141(8):2529-35. PubMed ID: 3171178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Certain characteristics of human lymphocyte migration inhibitory factors (LyMIF) and the effect of ampicillin on their appearance in unstimulated and PHA-stimulated cultures.
    Skopińska-Rózewska E; Madaliński W; Lukasik R
    Acta Physiol Pol; 1983; 34(3):353-67. PubMed ID: 6372368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a low molecular weight suppressor of lymphocyte proliferation from guinea pig L2C leukemia cells.
    Collins DP; Cook DJ; Ricardo MJ
    Cell Immunol; 1987 Apr; 105(2):397-410. PubMed ID: 3494530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.